Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A.P. Pharma Names New Vice President of Clinical Development.


REDWOOD CITY Redwood City, city (1990 pop. 66,072), seat of San Mateo co., W Calif., on San Francisco Bay; inc. 1868. Manufactures include commmunications, electrical, electronic, and medical equipment. , Calif. -- A.P. Pharma, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:APPA), a specialty pharmaceutical company, today announced that Anastassios D. Retzios, Ph.D. has joined the Company in the newly created position of Vice President of Clinical Development, reporting to Gregory Turnbull, the Company's Chief Executive Officer. Dr. Retzios has more than 18 years of experience in a wide range of clinical and regulatory matters, most recently as Director of Global Clinical Research and Development at Baxter BioScience. Previously he served in senior clinical positions at Questcor Pharmaceuticals and Alpha Therapeutic Corporation.

In commenting on the appointment of Dr. Retzios, Mr. Turnbull said "we are delighted to have Anastassios on our team. The experience and expertise he brings to us will be of paramount importance as we pursue our pivotal phase 3 clinical trial phase 3 clinical trial Phase 3 study. See Phase study.  for APF APF,
n the abbreviation for acidulated phosphate fluoride.
530."

APF530 is the Company's lead compound for the prevention of both acute and delayed chemotherapy-induced nausea and vomiting Nausea and Vomiting Definition

Nausea is the sensation of being about to vomit. Vomiting, or emesis, is the expelling of undigested food through the mouth.
.

About A.P. Pharma

A.P. Pharma is a specialty pharmaceutical company focused on the development of ethical (prescription) pharmaceuticals utilizing its proprietary polymer-based drug delivery systems. The Company's primary focus is the development and commercialization of its bioerodible injectable in·ject·a·ble
adj.
Capable of being injected. Used of a drug.

n.
A drug or medicine that can be injected.
 and implantable systems under the trade name Biochronomer[TM]. Initial target areas of application for the Company's drug delivery technology include anti-nausea, pain management, anti-inflammation and DNA/RNAI applications. For further information visit the Company's web site at www.appharma.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 20, 2006
Words:233
Previous Article:New York Life Donates $150,000 to the MDRT Foundation.
Next Article:Jennifer Rotondo Joins NBIS as Web/Online Media Manager.
Topics:



Related Articles
BioChem Pharma Announces Senior Appointments.
JURILAB LAUNCHES NEW DRUG METABOLISM ENZYME TEST.
A.P. Pharma to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference.
Biovail Names Gilbert Godin Senior Vice-President.
Dr. Gerard T. Kennealey Joins MGI PHARMA as Senior Vice President, Clinical Development.
Results of the Annual Meeting of Stockholders of SCOLR Pharma, Inc. held on June 8, 2006; Company Names Rick Levy as Chief Financial Officer.
Tranzyme Pharma Appoints Industry Veteran as Senior Vice President of Research and Preclinical Development; Dr. Helmut Thomas to Lead Company's R &D...
A.P. Pharma Names Arthur Taylor to Board of Directors.
Tracy Lawhon, J.D., Joins Cabrellis Pharmaceuticals as Vice President, Regulatory Affairs and Development Operations.
ProNAi Announces Executive Team Buildup, Names New CEO and Top Development Management.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles